Clinical Research Directory
Browse clinical research sites, groups, and studies.
Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation
Sponsor: The Cleveland Clinic
Summary
Participants will undergo evaluation with the Atmo capsule at two time points: at baseline before starting the GLP-1RA or dual agonist therapy and after the subject has been taking their GLP-1RA or dual agonist therapy for 3 months. The total expected time for patient participation is up to 4 months from the time they start their GLP-1RA or dual agonist therapy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-12
Completion Date
2028-12
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Interventions
Gut motility quantification using a capsule after initiating GLP-1RA therapy
Participants will undergo evaluation with the Atmo capsule at two time points: at baseline before starting the GLP-1RA or dual agonist therapy and after the subject has been taking their GLP-1RA or dual agonist therapy for 3 months. The total expected time for patient participation is up to 4 months from the time they start their GLP-1RA or dual agonist therapy.
Locations (1)
Cleveland Clinic
Cleveland, Ohio, United States